May 9, 2023 Bariatric Medicine The claim that semaglutide (Ozempic) leads to temporary hair loss is not a side effect of the drug but a normal physiological response when we lose weight.
March 30, 2023 Bariatric Medicine Limited evidence that COVID -19 infection during pregnancy could lead to a greater risk of childhood obesity. Much more evaluation required to determine is there is a plausible mechanism involved in the process and if this is true.
March 9, 2023 Bariatric Medicine Despite social media buzz, Ozempic is a valuable addition to support people struggling with their weight. It has changed many of my patient’s lives for the better (remission of DM2, fatty liver disease, sleep apnea, osteoarthritic pain, depression…)
March 7, 2023 Bariatric Medicine Many established factors in the calculation of heart disease risk must be considered when interpreting the results of a study that states that the ‘keto-like’ diet may be linked to increasing that risk.
December 19, 2022 Bariatric Medicine Meta-analyses of randomized controlled trials looks at efficacy of semaglutide (Ozempic) in treating people suffering with obesity
December 15, 2022 Bariatric Medicine Diabetes drug in short supply in U.S. (but not in Canada) after celebrities, influencers touted its weight-loss benefits.
November 29, 2022 Bariatric Medicine Just a little, ok, a lot of hyperbole in this article reviewing this observational study that claims intermittent fasting can “send you to an early grave”. Once again, no causal relationship and plenty of confounding factors.
June 8, 2022 Bariatric Medicine Wegovy (semaglutide) approved by FDA to support people struggling to lose weight (and that includes many). Health Canada did so in November 2021. Major addition to weight-loss management options.
May 11, 2022 Bariatric Medicine Treatments for weight loss do exist, work well for many, and reveal our growing understanding of how our homeostatic, motivational, and executive brain centers interact with respect to weight control.
March 5, 2021 Bariatric Medicine Covid-19 mortality rates up to 10 times greater in countries where overweight rates are greater than 50% of the population.
